TERT and urinary bladder carcinoma: In another study, TERT promoter mutation was significantly associated with 6-month recurrence of pT1 bladder cancer presence of TERT mutation increased the risk of recurrence 5-fold, and TERT promoter hotspots could be used to non-invasively follow up non-muscle invasive bladder cancer patients after surgery (26).